Prescient, a biopharma product and portfolio strategy firm, agreed to acquire Strategic North, a global commercial strategy consultancy. Financial terms were not disclosed. "We are hugely excited to be joining the Prescient team. Our vision has always been about providing our clients with seamlessly integrated, best-in-class specialist skills and this partnership enables us to do this in an even bigger and better way. Our core objectives for 2022 will be to effectively integrate our respective teams and cultures, expand the Strategic North capability in the US and further differentiate our core service lines by leveraging our combined capabilities," Steve Padgett, Strategic North Co-Founder and Managing Director.